日本大阪和马萨诸塞州坎布里奇--(BUSINESS WIRE)--(美国商业资讯)-- Takeda (TSE:4502/NYSE:TAK) 今天宣布，欧洲药品管理局(EMA)人用医药产品委员会(CHMP)建议批准HYQVIA ® [10%免疫球蛋白（人体）注射液结合重组人体透明质酸酶]用于慢性炎症性脱髓鞘性多神经病变(CIDP)患者 ...

日本大阪和马萨诸塞州剑桥--(BUSINESS WIRE)--(美国商业资讯)-- Takeda(TSE:4502/NYSE:TAK)今天公布了3期ADVANCE-CIDP 3临床试验的数据，这是 ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) results in disability through immune-mediated nerve injury, which can lead to irreversible deficits after the inflammatory component of CIDP is ...

Learn the key differences between CIDP and GBS, including causes, onset, and treatments, to ensure you get the correct ...